Results 101 to 110 of about 76,143 (164)

Deciding how to decide the correct double-lumen tube: a narrative review of methods and evidence. [PDF]

J Anesth Analg Crit Care
Rispoli M, Calgaro G, Strano G, Rosboch GL, Massullo D, Piccirillo F, Nespoli MR, Coppolino F, Piccioni F.   +8 more
europepmc   +1 more source

Practices of Sizing of Left-Sided Double Lumen Tubes at a Tertiary-Referral Cancer Centre in India: A Retrospective Cohort Study. [PDF]

Ann Card Anaesth
Kinra M, Parab S, Shetmahajan M, Salunke B, Ranganathan P.   +4 more
europepmc   +1 more source

Distributed ledger technology (DLT) : introduction

, 2018
Distributed ledger technology is attracting the attention of the financial sector, both owing to its use in transactions with crypto-assets and to the proliferation of initiatives which have the potential to increase the efficiency, transparency, speed and resilience of processes underlying financial transactions.
openaire   +1 more source

Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights. [PDF]

Clin Cancer Res
Brodsky AL, Asare A, Fellman B, Anderson K, Yao J, Lee S, Tran H, Xu X, Liu J, Celestino J, Hajek RA, Morgan MB, Mohammad M, Soliman P, Shafer A, Sood AK, Bodurka D, Fleming ND, Onstad Grinsfelder M, Milojevic L, Jazaeri AA, Mills GB, Coleman RL, Westin SN.   +23 more
europepmc   +1 more source

Behavioral and demographic factors associated with glycemic control in adults with type 2 diabetes mellitus: a cross-sectional study. [PDF]

BMC Health Serv Res
Innab A, Kerari A.
europepmc   +1 more source

Efficacy and safety of patisiran for the treatment of acquired amyloid polyneuropathy in domino liver transplant recipients. [PDF]

Ther Adv Neurol Disord
Nedkova-Hristova V, Donadeu L, Baliellas C, González-Costello J, Lladó L, González-Vilatarsana E, Morales de la Prida M, Vélez-Santamaría V, Bestard O, Casasnovas C.   +9 more
europepmc   +1 more source

Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial. [PDF]

Target Oncol
Rubio-San-Simón A, Marshall LV, Karamouza E, André N, Abbou S, Rubino J, Nebchi S, Aerts I, Thebaud E, Brisset C, Ducassou S, Le Teuff G, Geoerger B.   +12 more
europepmc   +1 more source

Improving Maximum Tolerated Dose Selection in Model-Assisted Designs for Phase I Trials Through Bayesian Dose-Response Model. [PDF]

Pharm Stat
Wakayama R, Momozaki T, Ando S.
europepmc   +1 more source

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. [PDF]

PLoS One
Kurokawa T, Iinuma T, Ebisu H, Yanagidaira T, Inaba Y, Fujiwara T, Hattori Y, Fukazawa T, Aoki T, Koseki H, Hanaoka H, Hanazawa T, Motohashi S.   +12 more
europepmc   +1 more source

A Decade of Oncolytic Virotherapy in Pediatric Cancers: A Systematic Review of Safety, Immune Awakening, and Emerging Efficacy. [PDF]

Cureus
BinSharhan AS, AlAbdullah AM, Alabdullatif SF, Aboushark YY, Alateeq NM, Alhajjaj WA, Alrabea HO, Saeedi F.   +7 more
europepmc   +1 more source